Could Brain Activity During Sleep Be a Biomarker for Alzheimer’s?

Changes in brain waves while snoozing correlate with accumulation of tau and amyloid-β, suggesting that the neural activity disruptions could clue doctors in to early development of the disease.

Written byAshley Yeager
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © istock.com, WIKIMEDIA, PATHO

The paper
J.R. Winer et al., “Sleep as a potential biomarker of tau and β-amyloid burden in the human brain,” J Neurosci, 39:6315–24, 2019.

Everybody sleeps, but not all sleep is created equal. Good sleep appears to keep the brain healthy, clearing toxins from the organ. But bad sleep might be a sign of neurodegenerative disease, with past studies linking sleep disturbances to the progression of Alzheimer’s disease.

Interested in whether brain waves correlated to accumulation of tau and amyloid-β, two proteins considered hallmarks of the disease, University of California, Berkeley, graduate student Joseph Winer and colleagues took positron emission tomography measures of the proteins in 31 cognitively healthy individuals in their 70s, then gathered electroencephalogram (EEG) readings of brain activity patterns while the participants slept.

Analyzing the data, the team found that the degree of synchronization of two types of brain waves prominent during sleep—bursts ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile

Published In

October 2019

Brain Fog

Air Pollution May Cause Cognitive Decline

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies